• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

回顾性分析血管免疫母细胞 T 细胞淋巴瘤的预后因素:日本多中心合作研究。

Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan.

机构信息

Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Blood. 2012 Mar 22;119(12):2837-43. doi: 10.1182/blood-2011-08-374371. Epub 2012 Feb 2.

DOI:10.1182/blood-2011-08-374371
PMID:22308294
Abstract

Angioimmunoblastic T-cell lymphoma (AITL) is a major type of peripheral T-cell lymphoma (PTCL). To elucidate the clinicopathologic characteristics and prognosis of AITL in Japan, we retrospectively analyzed 207 patients with AITL. The median patient age was 67 years (range, 34-91 years), with 73% of patients older than 60 years. With a median follow-up of 42 months in surviving patients, 3-year overall survival (OS) was 54% and progression-free survival (PFS) was 38%. The International Prognostic Index (IPI) and the prognostic index for PTCL, not otherwise specified (PIT) were predictive for OS in this analysis. Multivariate analysis found that age older than 60 years, elevated white blood cell (WBC) and IgA levels, the presence of anemia and thrombocytopenia, and extranodal involvement at > 1 site were significant prognostic factors for OS, and IgA, anemia, and mediastinal lymphadenopathy were significant prognostic factors for PFS. A novel prognostic model consisting of the prognostic factors for OS was successfully constructed. In conclusion, IPI and PIT were still useful for prognostication of AITL, and other factors, including those not used in IPI, such as IgA, anemia, WBC count, thrombocytopenia, and mediastinal lymphadenopathy, also significantly affected prognosis. Future investigations for IgA as a unique prognostic factor are warranted.

摘要

血管免疫母细胞性 T 细胞淋巴瘤(AITL)是外周 T 细胞淋巴瘤(PTCL)的主要类型之一。为了阐明日本 AITL 的临床病理特征和预后,我们回顾性分析了 207 例 AITL 患者。患者的中位年龄为 67 岁(范围为 34-91 岁),73%的患者年龄大于 60 岁。在存活患者的中位随访 42 个月中,3 年总生存率(OS)为 54%,无进展生存率(PFS)为 38%。国际预后指数(IPI)和未特指的外周 T 细胞淋巴瘤预后指数(PIT)在本分析中对 OS 具有预测作用。多变量分析发现,年龄大于 60 岁、白细胞(WBC)和 IgA 水平升高、存在贫血和血小板减少以及> 1 个部位的结外累及是 OS 的显著预后因素,而 IgA、贫血和纵隔淋巴结肿大是 PFS 的显著预后因素。成功构建了一个包含 OS 预后因素的新的预后模型。总之,IPI 和 PIT 仍然对 AITL 的预后有帮助,其他因素,包括那些未在 IPI 中使用的因素,如 IgA、贫血、WBC 计数、血小板减少和纵隔淋巴结肿大,也显著影响预后。未来有必要对 IgA 作为一个独特的预后因素进行研究。

相似文献

1
Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan.回顾性分析血管免疫母细胞 T 细胞淋巴瘤的预后因素:日本多中心合作研究。
Blood. 2012 Mar 22;119(12):2837-43. doi: 10.1182/blood-2011-08-374371. Epub 2012 Feb 2.
2
Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.血清IgA水平、单核细胞计数和国际预后指数与HTLV-I阴性淋巴结外周T细胞淋巴瘤患者的总生存期独立相关。
Ann Hematol. 2014 Jul;93(7):1185-91. doi: 10.1007/s00277-014-2025-0. Epub 2014 Feb 14.
3
Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.异质性外周 T 细胞淋巴瘤和血管免疫母细胞性 T 细胞淋巴瘤患者干细胞移植的疗效。
Int J Hematol. 2020 Jul;112(1):74-83. doi: 10.1007/s12185-020-02879-w. Epub 2020 Apr 15.
4
Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.滤泡辅助 T 细胞淋巴瘤国际预后指数的全面比较。
Ann Hematol. 2022 Jul;101(7):1535-1543. doi: 10.1007/s00277-022-04805-y. Epub 2022 May 31.
5
[Clinical characteristics and prognosis in 84 patients with angioimmunoblastic T-cell lymphoma: a single-center analysis].84例血管免疫母细胞性T细胞淋巴瘤患者的临床特征与预后:一项单中心分析
Zhonghua Xue Ye Xue Za Zhi. 2020 Nov 14;41(11):915-920. doi: 10.3760/cma.j.issn.0253-2727.2020.11.006.
6
Elevated absolute monocyte count predicts unfavorable outcomes in patients with angioimmunoblastic T-cell lymphoma.绝对单核细胞计数升高预示血管免疫母细胞性T细胞淋巴瘤患者预后不良。
Leuk Res. 2016 Mar;42:88-92. doi: 10.1016/j.leukres.2015.12.010. Epub 2015 Dec 24.
7
Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.比较不适合移植的外周 T 细胞淋巴瘤非特指型和血管免疫母细胞性 T 细胞淋巴瘤患者的预后评分:来自日本国立医院组织的回顾性研究。
Leuk Lymphoma. 2021 Apr;62(4):819-827. doi: 10.1080/10428194.2020.1845336. Epub 2020 Nov 9.
8
Clinicopathologic characteristics, outcomes, and prognostic factors of angioimmunoblastic T-cell lymphoma in China.中国侵袭性免疫母细胞性 T 细胞淋巴瘤的临床病理特征、结局和预后因素。
Cancer Med. 2023 Feb;12(4):3987-3998. doi: 10.1002/cam4.5248. Epub 2022 Sep 15.
9
Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor.中国血管免疫母细胞性T细胞淋巴瘤的临床特征及C反应蛋白作为独立预后因素
Medicine (Baltimore). 2017 Sep;96(39):e8091. doi: 10.1097/MD.0000000000008091.
10
Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy.外周 T 细胞淋巴瘤预后因素分析:血清白蛋白和纵隔淋巴结肿大的预后价值。
Leuk Lymphoma. 2009 Dec;50(12):1999-2004. doi: 10.3109/10428190903318311.

引用本文的文献

1
Low prognostic nutritional index predicts poor outcome in newly diagnosed angioimmunoblastic T-cell lymphoma.低预后营养指数预示新诊断血管免疫母细胞性T细胞淋巴瘤预后不良。
Front Nutr. 2025 Jun 26;12:1622691. doi: 10.3389/fnut.2025.1622691. eCollection 2025.
2
Real-world data on clinical outcomes and validation of prognostic models for angioimmunoblastic T-cell lymphoma: a multicentric retrospective study in Southern China.血管免疫母细胞性T细胞淋巴瘤临床结局的真实世界数据及预后模型验证:中国南方多中心回顾性研究
Front Oncol. 2025 Jun 10;15:1580370. doi: 10.3389/fonc.2025.1580370. eCollection 2025.
3
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma.
综合基因组和转录组分析揭示血管免疫母细胞性T细胞淋巴瘤中可靶向的脆弱性。
Am J Hematol. 2025 Sep;100(9):1486-1501. doi: 10.1002/ajh.27736. Epub 2025 Jun 13.
4
Real-World Data on the p.Gly17Val RHOA Mutation in Diagnosing T Follicular Helper Cell Lymphomas.用于诊断T滤泡辅助细胞淋巴瘤的p.Gly17Val RHOA突变的真实世界数据。
Cancer Med. 2025 May;14(9):e70955. doi: 10.1002/cam4.70955.
5
TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma.TP53和CDKN2A改变定义了淋巴结T滤泡辅助细胞淋巴瘤患者的一个预后不良亚组。
Leukemia. 2025 May 2. doi: 10.1038/s41375-025-02631-5.
6
Advancing the understanding and management of angioimmunoblastic T-cell lymphoma: insights into its pathogenesis, clinical features, and emerging therapeutic strategies.增进对血管免疫母细胞性T细胞淋巴瘤的理解与管理:对其发病机制、临床特征及新兴治疗策略的见解
Front Oncol. 2025 Mar 3;15:1479179. doi: 10.3389/fonc.2025.1479179. eCollection 2025.
7
Angioimmunoblastic T-cell lymphoma: Characterization of clonal T and B cells and a patient-derived xenograft study of coexisting T- and B-cell proliferation.血管免疫母细胞性T细胞淋巴瘤:克隆性T细胞和B细胞的特征以及共存T细胞和B细胞增殖的患者来源异种移植研究
EJHaem. 2025 Jan 28;6(1):e1080. doi: 10.1002/jha2.1080. eCollection 2025 Feb.
8
A Murine Database of Structural Variants Enables the Genetic Architecture of a Spontaneous Murine Lymphoma to be Characterized.一个小鼠结构变异数据库能够对一种自发性小鼠淋巴瘤的遗传结构进行表征。
bioRxiv. 2025 Jan 14:2025.01.09.632219. doi: 10.1101/2025.01.09.632219.
9
An exploratory study on the differential diagnostic indicators between adult systemic EBV-positive T-cell lymphoproliferative disorders and angioimmunoblastic T-cell lymphoma with multiple EBV infections.成人系统性EB病毒阳性T细胞淋巴增殖性疾病与伴有多重EB病毒感染的血管免疫母细胞性T细胞淋巴瘤鉴别诊断指标的探索性研究
Infect Agent Cancer. 2025 Jan 22;20(1):3. doi: 10.1186/s13027-024-00627-x.
10
Prognostic Utility of a Novel Prognostic Model Consisting of Age, CRP, Ki67, and POD24 in Patients with Angioimmunoblastic T-Cell Lymphoma.由年龄、C反应蛋白、Ki67和POD24组成的新型预后模型在血管免疫母细胞性T细胞淋巴瘤患者中的预后价值
Indian J Hematol Blood Transfus. 2024 Oct;40(4):613-620. doi: 10.1007/s12288-024-01767-1. Epub 2024 Apr 12.